Lipid Luminations
From The Journals

Lipid Luminations is a column devoted to insights and reports on recent medical topics. Dr. Goldberg is Director of the Lipid Disorder Unit, Diabetes Research Institute, University of Miami, School of Medicine.

What to make of the Enhance Study?

On-Treatment HDL-C Levels Matter In Statin-Treated Subjects with CVD

Safety of Statins – A Meta-Analysis of the Incidence of Raised Liver Enzymes, Rhabdomyolysis and Cancer in Clinical Trials with Statins

Whither HDL-C Raising?

CAD and high HDL

High-Dose Atorvastatin after Stroke or Transient Ischemic Attack

Should maximum dose statin therapy be routinely used to prevent coronary heart disease and stroke in secondary prevention?

New Approaches to the Management of Obesity and the Metabolic Syndrome?

A Tale of Two PPAR Agonists

Taking a Pill to Boost HDL Function in Mice

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

C-reactive protein levels and outcomes after statin therapy

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the CARDS Study

Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis.

Raising High-Density Lipoprotein in Humans Through Inhibition of Cholesteryl Ester Transfer Protein

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin

Markers of Inflammation and Cardiovascular Disease. Application to Clinical and Public Health Practice.

Do statins have important clinical effects beyond lowering of LDL-cholesterol

Statins and Risk of Polyneuropathy

Platelet Receptor Inhibition in Ischemic Syndrome Management

Non-High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality